{"id":401407,"date":"2020-12-16T17:29:08","date_gmt":"2020-12-16T22:29:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401407"},"modified":"2020-12-16T17:29:08","modified_gmt":"2020-12-16T22:29:08","slug":"hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/","title":{"rendered":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n SAN FRANCISCO<\/span>, Dec. 16, 2020<\/span> \/PRNewswire\/\u00a0—\u00a0<\/b>Hagens Berman urges Penumbra, Inc. (NYSE: PEN) <\/b>investors to submit their losses now.<\/a>\u00a0 The firm is investigating possible securities law violations.<\/p>\n

\n

\n
\n \"Hagens
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Visit:<\/b>\u00a0www.hbsslaw.com\/investor-fraud\/PEN<\/a>
Contact An Attorney Now:<\/b>\u00a0PEN@hbsslaw.com<\/a>\u00a0
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 844-916-0895<\/b><\/p>\n

\n Penumbra, Inc. (PEN) Investigation: <\/b>\n <\/p>\n

The investigation centers on whether Penumbra misled investors about the company’s flagship products for treating ischemic stroke. \u00a0<\/p>\n

On Nov. 9, 2020<\/span>, Quintessential Capital Management <\/i>(“QCM”<\/i>)\u00a0published a scathing report, “Penumbra and its ‘killer catheter.'” QCM <\/i>concluded: (1) “Penumbra’s flagship ‘Jet 7’ device is linked to 18 recorded deaths, 39 injuries: this might be only the ‘tip of the iceberg;'” (2) “[t]he device is unsafe and unmarketable: we believe an FDA class 1 recall highly likely; (3) “Penumbra may have been highly misleading in critical parts of its communication with doctors and investors;” and, (4) “[d]espite appearances, financial metrics are rapidly deteriorating, anticipating a possible sharp drop in sales.”<\/p>\n

Then, on Dec. 8, 2020<\/span>, QCM <\/i>published another report accusing Penumbra of having engaged in a multi-year scheme to fraudulently produce a substantial portion of scientific literature using a fake character to support its product marketing to healthcare providers.\u00a0 According to QCM<\/i>, “[t]his fraudulent character appears to have been fabricated by management in a reckless attempt to hide its involvement with critical research produced with significant undisclosed conflicts of interest.”<\/p>\n

\n Later that day, Penumbra admitted its co-founder, Arani Bose<\/span>, was the real author<\/b>\u00a0of published scientific literature supportive of the company’s activities.<\/p>\n

\n Most recently, on Dec. 15, 2020<\/span>, Penumbra announced it is voluntarily recalling all configurations of its JET 7 Xtra Flex device<\/b>\u00a0because it may be susceptible to damage during use and subsequent patient injury or death.<\/p>\n

These events have driven the price of Penumbra shares sharply lower.<\/p>\n

“We’re focused on, among other things, investor losses and whether Penumbra misled investors about the Jet 7 safety and by using a fictional author to support its business activities,” said Reed Kathrein<\/span>, the Hagens Berman partner leading the investigation. <\/p>\n

If you are a Penumbra investor or have information that may assist our investigation, click here to discuss your legal rights with Hagens Berman<\/a>.<\/p>\n

\n Whistleblowers: <\/b>Persons with non-public information regarding Penumbra should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. \u00a0Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. \u00a0For more information, call Reed Kathrein<\/span> at 844-916-0895<\/b> or email PEN@hbsslaw.com<\/a>.<\/p>\n

\n
\n About Hagens Berman<\/a>
\n <\/u>
\n
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys.\u00a0 The firm represents investors, whistleblowers, workers and consumers in complex litigation.\u00a0 More about the firm and its successes is located at hbsslaw.com<\/a>. \u00a0For the latest news visit our newsroom<\/a><\/u> or follow us on Twitter at @classactionlaw<\/a><\/u>.<\/p>\n

\n Contact:
<\/u>
\n Reed Kathrein<\/span>, 844-916-0895<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now-301194505.html<\/a><\/p>\n

SOURCE Hagens Berman Sobol Shapiro LLP<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire SAN FRANCISCO, Dec. 16, 2020 \/PRNewswire\/\u00a0—\u00a0Hagens Berman urges Penumbra, Inc. (NYSE: PEN) investors to submit their losses now.\u00a0 The firm is investigating possible securities law violations. Visit:\u00a0www.hbsslaw.com\/investor-fraud\/PENContact An Attorney Now:\u00a0PEN@hbsslaw.com\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 844-916-0895 Penumbra, Inc. (PEN) Investigation: The investigation centers on whether Penumbra misled investors about the company’s flagship products for treating ischemic stroke. \u00a0 On Nov. 9, 2020, Quintessential Capital Management (“QCM”)\u00a0published a scathing report, “Penumbra and its ‘killer catheter.’” QCM concluded: (1) “Penumbra’s flagship ‘Jet 7’ device is linked to 18 recorded deaths, 39 injuries: this might be only the ‘tip of the iceberg;’” (2) “[t]he device is unsafe and unmarketable: we believe an FDA class 1 recall highly likely; (3) “Penumbra may have been highly misleading in … <\/p>\n

Continue reading “HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401407","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire SAN FRANCISCO, Dec. 16, 2020 \/PRNewswire\/\u00a0—\u00a0Hagens Berman urges Penumbra, Inc. (NYSE: PEN) investors to submit their losses now.\u00a0 The firm is investigating possible securities law violations. Visit:\u00a0www.hbsslaw.com\/investor-fraud\/PENContact An Attorney Now:\u00a0PEN@hbsslaw.com\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 844-916-0895 Penumbra, Inc. (PEN) Investigation: The investigation centers on whether Penumbra misled investors about the company’s flagship products for treating ischemic stroke. \u00a0 On Nov. 9, 2020, Quintessential Capital Management (“QCM”)\u00a0published a scathing report, “Penumbra and its ‘killer catheter.'” QCM concluded: (1) “Penumbra’s flagship ‘Jet 7’ device is linked to 18 recorded deaths, 39 injuries: this might be only the ‘tip of the iceberg;'” (2) “[t]he device is unsafe and unmarketable: we believe an FDA class 1 recall highly likely; (3) “Penumbra may have been highly misleading in … Continue reading "HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T22:29:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now\",\"datePublished\":\"2020-12-16T22:29:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/\"},\"wordCount\":514,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/450112\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/\",\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/450112\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg\",\"datePublished\":\"2020-12-16T22:29:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/450112\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/450112\\\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/","og_locale":"en_US","og_type":"article","og_title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk","og_description":"PR Newswire SAN FRANCISCO, Dec. 16, 2020 \/PRNewswire\/\u00a0—\u00a0Hagens Berman urges Penumbra, Inc. (NYSE: PEN) investors to submit their losses now.\u00a0 The firm is investigating possible securities law violations. Visit:\u00a0www.hbsslaw.com\/investor-fraud\/PENContact An Attorney Now:\u00a0PEN@hbsslaw.com\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 844-916-0895 Penumbra, Inc. (PEN) Investigation: The investigation centers on whether Penumbra misled investors about the company’s flagship products for treating ischemic stroke. \u00a0 On Nov. 9, 2020, Quintessential Capital Management (“QCM”)\u00a0published a scathing report, “Penumbra and its ‘killer catheter.'” QCM concluded: (1) “Penumbra’s flagship ‘Jet 7’ device is linked to 18 recorded deaths, 39 injuries: this might be only the ‘tip of the iceberg;'” (2) “[t]he device is unsafe and unmarketable: we believe an FDA class 1 recall highly likely; (3) “Penumbra may have been highly misleading in … Continue reading \"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T22:29:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now","datePublished":"2020-12-16T22:29:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/"},"wordCount":514,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/","name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company's Admissions, Encourages Investors to Contact its Attorneys Now - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg","datePublished":"2020-12-16T22:29:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/450112\/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-continues-penumbra-pen-fraud-investigation-in-light-of-companys-admissions-encourages-investors-to-contact-its-attorneys-now\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Continues Penumbra (PEN) Fraud Investigation In Light Of Company’s Admissions, Encourages Investors to Contact its Attorneys Now"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401407"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401407\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}